In 60 patients with acute intermediate-high-risk pulmonary embolism (58 analysed), low-dose, short-duration catheter-directed thrombolysis plus UFH improved RV/LV ratio at 24 h vs UFH alone (−0.17 vs +0.02; p=0.01). Secondary endpoints did not differ; no major bleeding.
RCTn = 60
Schultz et al. Low-dose, short-duration catheter-directed thrombolysis for acute intermediate-high-risk pulmonary embolism: the BETULA trial